Phase I Study of LNF1901 in Advanced Malignant Tumors
Clinical trial NCT06226363 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06226363
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-02-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.